EUVIMEDEUVIMED entdecken
FallberichtLeserbrief

Successful utilization of topical trametinib for neurofibromatosis type I‐associated plexiform neurofibroma

Leonid Melnikov iD, Lars Brichta iD, Nathan J Schloemer

Pediatric Dermatology · 2024

DOI: 10.1111/pde.15710 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Pediatric Dermatology, 2024. Verfasst von Leonid Melnikov und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology-Oncology, East Tennessee Children's Hospital, Knoxville, Tennessee, USA. Hauptthemen laut MEDLINE: Pyrimidinones, Pyridones, Neurofibroma, Plexiform, Neurofibromatosis 1. Die Arbeit nennt 5 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

An 11‐year‐old female with neurofibromatosis type 1 (NF‐1) and history of optic glioma presented with a progressive cutaneous plexiform neurofibroma of the breast. The lesion was treated with topical application of a mitogen‐activated protein kinase inhibitor, trametinib, resulting in stable, non‐progression cutaneous plexiform neurofibroma for greater than 2 years. This case demonstrates the potential application of topical trametinib for NF1‐associated superficial cutaneous plexiform neurofibroma without the toxicities associated with systemic treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyrimidinonesPyridonesNeurofibroma, PlexiformNeurofibromatosis 1HumansFemaleChildAdministration, TopicalSkin NeoplasmsProtein Kinase Inhibitors

Stichwörter der Autor:innen

administrationdermatologyneurofibromatosispediatricplexiform neurofibromatherapeutictopicaltrametinib

Substanzen

PyrimidinonesPyridonestrametinibProtein Kinase Inhibitors

Autor:innen und Institutionen

  • Department of Hematology-Oncology, East Tennessee Children's Hospital, Knoxville, Tennessee, USA.
  • Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
  • Chemistry Rx, Folcroft, Pennsylvania, USA.

ORCID-Profile: Leonid Melnikov, Lars Brichta

Zitieren

APA

Melnikov, L., Brichta, L., & Schloemer, N. J. (2024). Successful utilization of topical trametinib for neurofibromatosis type I‐associated plexiform neurofibroma. Pediatric Dermatology. https://doi.org/10.1111/pde.15710

Vancouver

Melnikov L, Brichta L, Schloemer NJ. Successful utilization of topical trametinib for neurofibromatosis type I‐associated plexiform neurofibroma. Pediatric Dermatology. 2024. doi:10.1111/pde.15710

BibTeX
@article{Melnikov2024,
  author = {Melnikov, Leonid and Brichta, Lars and Schloemer, Nathan J},
  title = {Successful utilization of topical trametinib for neurofibromatosis type I‐associated plexiform neurofibroma},
  journal = {Pediatric Dermatology},
  year = {2024},
  doi = {10.1111/pde.15710}
}
Kostenlos starten →